Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hobbic Study Incorporated is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution activity is limited to 1 distinct art unit and 1 distinct examiner, indicating a very specific and focused engagement with the patent office. This concentration allows for a targeted approach to the single pending matter, as there are no competing priorities or differing examiner styles to balance within the current portfolio.
GULLEDGE, BRIAN M is the busiest examiner for the portfolio, overseeing the 1 pending office action. As the only examiner currently reviewing the company's work, this individual's interpretation of biotechnology and pharmaceutical standards will be the primary factor in the prosecution outcome. Practitioners should focus on the specific precedents and guidelines followed within this 1 distinct art unit. Since the company only has a single pending matter, the strategic focus is entirely on the 1 distinct examiner, making it essential to understand their specific history of allowances and rejections in this technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GULLEDGE, BRIAN M | 1 | 55.8% | +26.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16399772 | BODYPAINTING INKS, BODYPAINTING INSTRUMENTS AND METHODS FOR MANUFACTURING BODYPAINTING INKS | GULLEDGE, BRIAN M | 55d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16399772 | BODYPAINTING INKS, BODYPAINTING INSTRUMENTS AND METHODS FOR MANUFACTURING BODYPAINTING INKS | GULLEDGE, BRIAN M | 55d |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16399772 | BODYPAINTING INKS, BODYPAINTING INSTRUMENTS AND METHODS FOR MANUFACTURING BODYPAINTING INKS | GULLEDGE, BRIAN M | 1699 | §102§103 | Non-Final OA | 55d | Pending | Apr 30, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial